Τόμος 34 (2020) – Τεύχος 1 –Άρθρο 5 – Review of Clinical Pharmacology and Pharmacokinetics – Διεθνής Έκδοση – Volume 34 (2020) – Issue 1 – Article 5 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Vasiliki Kefala¹,Foteini Biskanaki²

¹Aesthetician Cosmetologist, Pharmacist Professor, Laboratory of Dermatology-Aesthetics-laser applications (lablad) ,Sector of Aesthetics and Cosmetology, Department of Biomedical Sciences.  Faculty of Health Sciences and Welfare .University of West Attica. Campus 1.Athens .Greece

²Aesthetician Cosmetologist MSc, PhDc, Academic Scholar, Laboratory of Dermatology-Aesthetics-laser applications (lablad),Sector of Aesthetics and Cosmetology, Department of Biomedical Sciences. .  Faculty of Health Sciences and Welfare University of West Attica.Campus 1.Athens. Greece

The skin supports a delicate ecosystem of microbial elements. Although the skin acts as a barrier these microbes interact with the internal environment of the body, disturbing the balance resulting in the appearance of several dermatologic diseases. Understanding the changes in the microbial flora of our skin is enabled to heal the problem and restore balance. There is a recent increase in the popularity of holistic and natural such as prebiotics, probiotics, symbiotic. Studies are being made to find alternative treatments to treat skin disorders through manipulation or supplementation of the microbiome.

1. Bouslimani A, Porto C, Rath CM, et al. Molecular cartography of the humanskin surface in 3D. Proc Natl AcadSci U S A.112:E2120-2129. (2015)
2. Findley K, Oh J, Yang J, et al. Topographic diversity of fungal and bacterialcommunities in human skin. Nature.498:367-370. (2013)
3. Foulongne V, Sauvage V, Hebert C, et al. Human skin microbiota: highdiversity of DNA viruses identified on the human skin by high throughputsequencing. PLoS One., 7, e38499. (2012)
4. Hannigan GD, Meisel JS, Tyldsley AS, et al. The human skin doublestrandedDNA virome: topographical and temporal diversity, genetic enrichment,and dynamic associations with the host microbiome. MBio.,6:e01578-01515. (2015)
5. Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol., 9:244-253.(2011)
6. Tauch A, KaiserO, Hain T, et al. Complete genome sequence and analysisof the multiresistant nosocomial pathogen Corynebacterium jeikeiumK411, a lipid-requiring bacterium of the human skin flora. J Bacteriol.,187:4671-4682. (2015)
7. Gallo RL, Nakatsuji T. Microbial symbiosis with the innate immunedefense system of the skin. J Invest Dermatol.,131:1974-1980. (2011)
8. Grice EA. The skin microbiome: potential for novel diagnostic and therapeuticapproaches to cutaneous disease. SeminCutan Med Surg., 33:98-103. (2014)
9. Zeeuwen PL, Boekhorst J, van den Bogaard EH, et al. Microbiome dynamicsof human epidermis following skin barrier disruption. GenomeBiol., 13:R101. (2012)
10. Arora M, Baldi A. Regulatory categories of probiotics across the globe: areview representing existing and recommended categorization. Indian JMed Microbiol. (33 Suppl):2-10. (2015)
11. Weyrich LS, Dixit S, Farrer AG, et al. The skin microbiome: associationsbetween altered microbial communities and disease. Australas J Derma, 56:268-274. (2015)
12. Perez Perez GI, Gao Z, Jourdain R, et al. Body site is a more determinantfactor than human population diversity in the healthy skin microbiome.PLoS One.11, e0151990. (2016)
13. Feingold KR, Grunfeld C., Psoriasis:it’s more than just the skin. J LipidRes.53:1427-1429. (2012)
14. Alekseyenko AV, Perez-Perez GI, De Souza A, et al. Community differentiationof the cutaneous microbiota in psoriasis. Microbiome.,1:31. (2013)
15. Drago L, De Grandi R, Altomare G, et al. Skin microbiota of first cousinsaffected by psoriasis and atopic dermatitis. ClinMolAllergy.,14:2. (2016)
16. Talib WH, Saleh S. Propionibacterium acnes augments antitumor, antiangiogenesisand immunomodulatory effects of melatonin on breast cancerimplanted in mice. PLoS One.,10, e0124384. (2015)
17. Dharmage SC, Lowe AJ, Matheson MC, et al. Atopic dermatitis and theatopic march revisited. ,69:17-27. (2014)
18. EyerichK,Novak N. Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy.,68:974-982. (2013)
19. Kong HH, Oh J, Deming C, et al. Temporal shifts in the skin microbiomeassociated with disease flares and treatment in children with atopic dermatitis.Genome Res., 22:850-859.(2012)
20. Wollenberg A, Feichtner K. Atopic dermatitis and skin allergies—updateand outlook. Allergy.,68:1509-1519. (2013)
21. Penders J, Gerhold K, Stobberingh EE, et al. Establishment of the intestinalmicrobiota and its role for atopic dermatitis in early childhood. J AllergyClinImmunol., 132:601-607. e608. (2013)
22. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesionsof atopic dermatitis. Br J Dermatol.90:525-530.(1974)
23. Bourrain M, Ribet V, Calvez A, et al. Balance between beneficial microfloraand Staphylococcus aureus colonisation: in vivo evaluation in patientswith atopic dermatitis during hydrotherapy. Eur J Dermatol.23:786-794.(2013)
24. Dotterud LK, Wilsgaard T, Vorland LH, et al. The effect ofUVB radiationon skin microbiota in patients with atopic dermatitis and healthy controls.Int J Circumpolar Health. 2008;67:254-260.
25. WilliamsMR, Gallo RL. The role of skin microbiome in atopic dermatitis.Curr Allergy Asthma Rep.11:65.(2015)
26. Lazaridou E, Giannopoulou C, Fotiadou C, et al. The potential role of microorganismsin the development of rosacea. 9:21-25.(2011)
27. Picardo M, Ottaviani M. Skin microbiome and skin disease: the exampleof rosacea. J Clin Gastroenterol.48:S85-S86.(2014)
28. Schommer NN, Gallo RL. Structure and function of the human skinmicrobiome. Trends Microbiol.21:660-668.(2013)
29. Jarmuda S, O’Reilly N, Zaba R, et al. Potential role of Demodex mitesand bacteria in the induction of rosacea. J Med Microbiol.61:1504-1510.(2012)
30. Kurokawa I, Danby FW, Ju Q, et al. New developments in our understandingof acne pathogenesis and treatment. Exp Dermatol.18:821-832.(2009)
31. Oh J, Conlan S, Polley EC, et al. Shifts in human skin and nares microbiotaof healthy children and adults. Genome Med.4:77.(2012)
32. Fitz-Gibbon S, Tomida S, Chiu BH, et al. Propionibacterium acnes strainpopulations in the human skin microbiome associated with acne. J InvestDermatol. 2013;133:2152-2160.
33. Troccaz M, Gaia N, Beccucci S, et al. Mapping axillary microbiota responsiblefor body odours using a culture-independent approach. Microbiome.2015;3:3.
34. James AG, Austin CJ, Cox DS, et al. Microbiological and biochemicalorigins of human axillary odour. FEMS Microbiol Ecol.83:527-540.(2013)
35. Barzantny H, Brune I, Tauch A. Molecular basis of human body odourformation: insights deduced from corynebacterial genome sequences. IntJ Cosmet Sci. 2012;34:2-11.
36. Callewaert C, Hutapea P, Van de Wiele T, et al. Deodorants and antiperspirantsaffect the axillary bacterial community. Arch Dermatol Res.306:701-710.(2014)
37. Urban J, Fergus DJ, Savage AM, et al. The effect of habitual and experimentalantiperspirant and deodorant product use on the armpit microbiome.4, e1605.(2016)
38. Soares RC, Camargo-Penna PH, de Moraes VC, et al. Dysbiotic bacterial and fungal communities not restricted to clinically affected skin sites indandruff. Front Cell Infect Microbiol.6:157.(2016)
39. Hill C, Guarner F, Reid G, et al. Expert consensus document. The InternationalScientific Association for Probiotics and Prebiotics consensus statementon the scope and appropriate use of the term probiotic. Nat RevGastroenterolHepatol., 11:506-514. (2014)
40. HutkinsRW, Krumbeck JA, Bindels LB, et al. Prebiotics: why definitionsmatter. CurrOpin Biotechnol.37:1-7.(2016)
41. Ceapa C, Wopereis H, Rezaiki L, et al. Influence of fermented milk products,prebiotics and probiotics on microbiota composition and health.BestPract Res Clin27:139-155.(2013)
42. Dimidi E, Christodoulides S, Scott SM, et al. Mechanisms of action ofprobiotics and the gastrointestinal microbiota on gut motility and constipation.Adv Nutr.8:484-494.(2017)
43. Sarowska J, Choroszy-Krol I, Regulska-Ilow B, et al. The therapeutic effectof probiotic bacteria on gastrointestinal diseases. AdvClinExp Med.22:759-766.(2013)
44. Rabah H, Rosa do Carmo FL, JanG. Dairy propionibacteria: versatile probiotics.Microorganisms.5.(2017)
45. Irecta-Najera CA, Del Rosario Huizar-Lopez M, Casas-Solis J, et al. Protectiveeffect of Lactobacillus casei on DMH-induced colon carcinogenesisin mice. Probiotics Antimicrob Proteins.9:163-171.(2017)
46. Verma A, Shukla G. Probiotics Lactobacillus rhamnosus GG, Lactobacillusacidophilus suppresses DMH-induced procarcinogenic fecal enzymesand preneoplastic aberrant crypt foci in early colon carcinogenesis in SpragueDawley rats. Nutr Cancer. 65:84-91(2013).
47. SharmaM, Shukla G. Metabiotics: one step ahead of probiotics; an insightinto mechanisms involved in anticancerous effect in colorectal cancer.Front Microbiol.7:1940.(2016)
48. Ely H. Is psoriasis a bowel disease? Successful treatment with bile acidsand bioflavonoids suggest it is. ClinDermatol.25:375-387.(2018)
49. Panduru M, Panduru NM, Salavastru CM, et al. Probiotics and primaryprevention of atopic dermatitis: a meta-analysis of randomized controlledstudies. J EurAcadDermatol Venereol.29:232-242.(2015)
50. Kim SO, Ah YM, Yu YM, et al. Effects of probiotics for the treatment ofatopic dermatitis:a meta-analysis of randomized controlled trials. Ann AllergyAsthma Immunol.13:217-226.(2014)
51. Elazab N, Mendy A, Gasana J, et al. Probiotic administration in early life,atopy, and asthma: a meta-analysis of clinical trials. Pediatrics.132:e666-676.(2013)
52. Pelucchi C, Chatenoud L, Turati F, et al. Probiotics supplementation duringpregnancy or infancy for the prevention of atopic dermatitis: a metaanalysis.Epidem.23:402-414.(2012)
53. Doege K, Grajecki D, Zyriax BC, et al. Impact of maternal supplementationwith probiotics during pregnancy on atopic eczema in childhood—ameta-analysis. Br J Nutr.;107:1-6.(2012)
54. Osborn DA, Sinn JK. Prebiotics in infants for prevention of allergy. CochraneDatabase Syst Rev.,(2013)
55. Kuitunen M. Probiotics and prebiotics in preventing food allergy and eczema.CurrOpin Allergy Clin Immunol.13:280-286.(2013)
56. Dang D, Zhou W, Lun ZJ, et al. Meta-analysis of probiotics and/or prebioticsfor the prevention of eczema. J Int Med Res. 41:1426-1436.(2013)
57. Chang YS, Trivedi MK, Jha A, et al. Synbiotics for prevention and treatmentof atopic dermatitis: a meta-analysis of randomized clinical trials.JAMA Pediatr.170:236-242.(2016)
58. Bowe W, Patel NB, Logan AC. Acne vulgaris, probiotics and the gutbrain-skin axis: from anecdote to translational medicine. Benef Microbes.5:185-199.(2014)
59. WangY, Kuo S, Shu M, et al. Staphylococcus epidermidis in the humanskin microbiome mediates fermentation to inhibit the growth of Propionibacteriumacnes: implications of probiotics in acne vulgaris.ApplMicrobiol Biotechnol.98:411-424.(2014)
60. Jung GW, Tse JE, Guiha I, et al. Prospective, randomized, open-label trialcomparing the safety, efficacy, and tolerability of an acne treatment regimenwith and without a probiotic supplement and minocycline in subjectswith mild to moderate acne. J Cutan Med Surg.17:114-122.(2013)
61. Kober MM, Bowe WP. The effect of probiotics on immune regulation,acne, and photoaging. IntJ Womens Dermatol.1:85-89.(2015)
62. Vaughn AR, Sivamani RK. Effects of fermented dairy products on skin: asystematic review. J Altern Complement Med. 21:380-385.(2015)
63. Drago F, De Col E, Agnoletti AF, et al. The role of small intestinal bacterialovergrowth in rosacea: a 3-year follow-up. J Am Acad Dermatol.75:e113-e115.(2016)
64. Fortuna MC, Garelli V, Pranteda G, et al. A case of scalp rosacea treatedwith low dose doxycycline and probiotic therapy and literature review ontherapeutic options. DermatolTher.29:249-251.(2016)
65. Tsiouris CG, KelesiM, VasilopoulosG, et al. The efficacy of probiotics aspharmacological treatment of cutaneous wounds: meta-analysis of animalstudies. Eur J PharmSci.104:230-239.(2017)
66. Pourramezan Z, KasraKermanshahi R, Oloomi M, et al. In vitro study ofantioxidant and antibacterial activities of Lactobacillus probiotic spp.Folia Microbiol (Praha)2017.
67. Sharma D, Kober MM, Bowe WP. Anti-aging effects of probiotics. JDrugs Dermatol. 15:9-12.(2016)
68. Park MR, Oh S, Son SJ, et al. Bacillus licheniformis Isolated from traditionalKorean food resources enhances the longevity of Caenorhabditiselegans through serotonin signaling. J Agric Food Chem. 63:10227-10233.(2015)
69. Koskella B, Meaden S. Understanding bacteriophage specificity in naturalmicrobial communities. Viruses. 5:806-823.(2015)
70. Salmond GP, Fineran PC.A century of the phage: past, present and future.Nat Rev Microbiol.13:777-786.(2015)
71. Abedon ST, Kuhl SJ, Blasdel BG, et al. Phage treatment of human infections.Bacteriophage. 1:66-85.(2011)
72. McCallin S, Brüssow H. Phage therapy: an alternative or adjunct to antibiotics?Emerg Top Life Sci.1:105LP-116.(2017)
73. BrandweinM, Steinberg D, Meshner S. Microbial biofilms and the humanskin microbiome. NPJ Biofilms Microbiomes.2:3.(2016)
74. Joncyk-Matysiak E, Weber-Dabrowska B, Zaczek M, et al. Prospects ofphage application in the treatment of acne caused by Propionibacteriumacnes. Front Microbiol. 8:164.(2017)